Efficacy of arbidol in COVID-19 patients: A retrospective study

doi:10.12998/wjcc.v9.i25.7350

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4488)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

225

WORD

HTML

1992

Figures (1-1)

146

Tables (1-4)

170

Sum=2631

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

313

Download

795

Sum=1108

Publishing Process of This Article

Item

Count

Browse

299

Download

450

Sum=749

Sep 6, 2021 (publication date) through Jul 21, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Sep 6, 2021; 9(25): 7350-7357
Published online Sep 6, 2021. doi: 10.12998/wjcc.v9.i25.7350

Table 1 Comparison of recovery time of various indicators between arbidol therapy group and non–antiviral treatment control group

	Arbidol treatment (n = 72)	None-antiviral treatment (n = 60)	P value	Difference (d)
Disease duration (d)¹	23.42 ± 6.92	29.60 ± 6.49	< 0.001	6.183
Days before 2 NAT negative results¹	21.61 ± 6.95	27.59 ± 6.39	< 0.001	5.983
Days before significantly improved chest CT outcome¹	18.33 ± 5.94	24.28 ± 5.35	< 0.001	5.949

¹t test. NAT: Nucleic acid testing; CT: Computed tomography.

Citation: Wei S, Xu S, Pan YH. Efficacy of arbidol in COVID-19 patients: A retrospective study. World J Clin Cases 2021; 9(25): 7350-7357
URL: https://www.wjgnet.com/2307-8960/full/v9/i25/7350.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i25.7350